Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Content of Se, GSH-Px activity and TAS in the serum of patients with multiple sclerosis (MS) and in the control group

From: Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis

  Selenium (μg/L) GSH – Px (U/L) TAS (mmol/L)
  Control group MS patients Control group MS patients Control group MS patients
mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD
  (n) (n) (n) (n) (n) (n)
All subject 79.2±20.6 55.2#± 16.2 8029.9± 2650.1 6676.1*± 2386.4 1.48± 0.41 1.03#± 0.37
(63) (101) (63) (101) (63) (101)
A) Smoking 87.6±24.4 54.9± 16.2 8548.4± 2221.5 6649.6± 2421.0 1.38± 0.31 0.95*A/B± 0.39
(26) (45) (26) (45) (26) (45)
B) No-smoking 79.4± 17.52 55.6±13.5 8536.1± 2919.6 6609.2± 1948.4 1.31± 0.41 1.14± 0.33
(37) (56) (37) (56) (37) (56)
C) Taking ID - 55.4± 17.8   6911.9± 2480.9   0.92#C/D± 0.34
(52) (52) (52)
D) No-taking ID - 58.6± 14.8   6684.5± 2433.1   1.31± 0.31
   (49)   (49)   (49)
  1. SD – standard deviation, n – number of subjects, ID - immunomodulatory drugs; p value, p<0,05 - *, p<0,01 - #.